Graphy Publications
Inspiring Innovations & Discoveries
International Journal of Diabetes & Clinical Diagnosis Volume 3 (2016), Article ID 3:IJDCD-119, 1 page
http://dx.doi.org/10.15344/2394-1499/2016/119
Letter to the Editor
Cystatin C Levels & Peripheral Arterial Disease in Type 2 Diabetes Mellitus Regarding Nephropathy

Abeer A. AL-Refai

Biochemistry Department, Faculty of Medicine, Menofia University, Shibin El Kom, Egypt
Dr. Abeer A. AL-Refai, Biochemistry Department, Faculty of Medicine, Menofia University, Shibin El Kom, Egypt; E-mail: drabeer1975@hotmail.com
06 August 2016; 27 October 2016; 29 October 2016
AL-Refai AA (2016) Cystatin C Levels & Peripheral Arterial Disease in Type 2 Diabetes Mellitus Regarding Nephropathy. Int J Diabetes Clin Diagn 3: 119. doi: http://dx.doi.org/10.15344/2394-1499/2016/119

References

  1. Brevetti G, Schiano V, Chiariello M (2008) Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis 197: 1-11. View
  2. Lepäntalo M, Fiengo L, Biancari F (2012) Peripheral arterial disease in diabetic patients with renal insufficiency: a review. Diabetes Metab Res Rev 28: 40-45. View
  3. O’Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, et al. (2005) Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study. Arch Intern Med 165: 2666-2670. View
  4. Huha JH, Choib EH, Lima JS, Leea MY, Chunga CH, et al. (2015) Serum cystatin C levels are associated with asymptomatic peripheral arterial disease in type 2 diabetes mellitus patients without overt nephropathy. Diabetes Res Clin Pract 108: 258-264. View